AstraZeneca PLC Stock price

Equities

AZN

GB0009895292

Pharmaceuticals

Real-time Estimate Cboe Europe 09:02:35 2024-03-28 am EDT 5-day change 1st Jan Change
10,720 GBX -0.20% Intraday chart for AstraZeneca PLC +2.76% +1.09%
Sales 2024 * 51.01B Sales 2025 * 54.61B Capitalization 210B
Net income 2024 * 8.97B Net income 2025 * 10.25B EV / Sales 2024 * 4.47 x
Net Debt 2024 * 17.99B Net Debt 2025 * 11.5B EV / Sales 2025 * 4.06 x
P/E ratio 2024 *
23.8 x
P/E ratio 2025 *
20.8 x
Employees 89,900
Yield 2024 *
2.29%
Yield 2025 *
2.4%
Free-Float 96.49%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on AstraZeneca PLC

1 day-0.34%
1 week+2.69%
Current month+7.26%
1 month+5.19%
3 months+1.27%
6 months-2.71%
Current year+1.02%
More quotes
1 week
10 314.00
Extreme 10314
10 780.00
1 month
9 982.00
Extreme 9982.0017
10 780.00
Current year
9 461.00
Extreme 9461
11 022.00
1 year
9 461.00
Extreme 9461
12 392.00
3 years
7 045.00
Extreme 7045
12 392.00
5 years
5 626.00
Extreme 5626
12 392.00
10 years
3 680.00
Extreme 3680
12 392.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 12-09-30
Director of Finance/CFO 50 21-07-31
Chief Tech/Sci/R&D Officer 56 19-12-31
Members of the board TitleAgeSince
Director/Board Member 65 17-09-30
Corporate Officer/Principal 59 13-01-31
Director/Board Member 63 17-04-26
More insiders
Date Price Change Volume
24-03-28 10,717 -0.24% 279 638
24-03-27 10,742 +2.89% 2,607,662
24-03-26 10,440 +0.44% 1,745,894
24-03-25 10,394 -0.84% 1,557,854
24-03-22 10,482 +0.52% 1,243,839

Delayed Quote London S.E., March 28, 2024 at 08:08 am EDT

More quotes
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
135.6 USD
Average target price
161.5 USD
Spread / Average Target
+19.04%
Consensus
  1. Stock
  2. Equities
  3. Stock AstraZeneca PLC - London S.E.